Taxis 2021-03: Determination of safety, tolerability and efficacy of submitted novel test articles

Project Details

StatusFinished
Effective start/end date3/03/21 → 2/03/22

Funding

  • TAXIS Pharmaceuticals, Inc.: $74,121.06

Keywords

  • Biotechnology & Drug Development, Infectious Diseases